Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Working Capital Changes: 2011-2025

Historic Other Working Capital Changes for Niagen Bioscience (NAGE) over the last 11 years, with Sep 2025 value amounting to -$233,000.

  • Niagen Bioscience's Other Working Capital Changes rose 43.31% to -$233,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 84.56%. This contributed to the annual value of -$732,000 for FY2024, which is 13.66% down from last year.
  • Per Niagen Bioscience's latest filing, its Other Working Capital Changes stood at -$233,000 for Q3 2025, which was down 210.67% from -$75,000 recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Other Working Capital Changes peaked at $2.8 million during Q3 2022, and registered a low of -$1.4 million during Q4 2022.
  • Over the past 3 years, Niagen Bioscience's median Other Working Capital Changes value was -$224,000 (recorded in 2024), while the average stood at -$208,900.
  • Per our database at Business Quant, Niagen Bioscience's Other Working Capital Changes surged by 203.26% in 2022 and then plummeted by 1,239.13% in 2023.
  • Niagen Bioscience's Other Working Capital Changes (Quarterly) stood at $202,000 in 2021, then plummeted by 787.62% to -$1.4 million in 2022, then skyrocketed by 108.86% to $123,000 in 2023, then crashed by 263.10% to -$411,000 in 2024, then surged by 43.31% to -$233,000 in 2025.
  • Its Other Working Capital Changes was -$233,000 in Q3 2025, compared to -$75,000 in Q2 2025 and -$405,000 in Q1 2025.